
Overview
I specialize in leukemia, myeloid neoplasm, adult bone marrow transplantation, and cellular therapies. I have been inspired by many patients and their loved ones going through the challenging journey to cure underlying leukemia and myeloid neoplasms and feel very privileged to serve them. I am dedicated to clinical research that aims to expand access to bone marrow transplantation and cellular therapies. I am passionate about improving the outcomes of adult bone marrow transplant patients by preventing the relapse of leukemia. In order to do this, we are developing a comprehensive machine learning algorithm to predict relapse after transplantation. I strive to make a meaningful difference in the treatment of patients with hematologic malignancies.
Dr. Hong is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Hong is board certified in American Board Of Internal Med, Internal Medicine , American Board Of Internal Med, Hematology , and American Board Of Internal Med, Medical Oncology. She is actively involved in clinical research, co-authoring 40 peer reviewed articles.
Graduate Institution
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE PDP
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
2400 Pratt St, Austell, GA 30106
20 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Febrile Neutropenia, Agranulocytosis, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Crawford is board certified in American Board Of Internal Med, Hematology/Oncology , American Board Of Internal Med, Internal Medicine , and American Board Of Internal Med, Medical Oncology.
Duke Cancer Center
Diane Reidy is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Reidy is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
Duke Cancer Center
I am a medical oncologist specializing in bone and soft tissue cancers called sarcomas. Sarcomas occur throughout the body, so I collaborate closely with colleagues from other specialties in a multidisciplinary team. I view my role in caring for someone's cancer as as privilege and strive to work together with each patient to ensure the best treatment decisions are made, all the while embracing each person's uniqueness as an individual. I see adult patients of all ages, but have a particular interest in the unique challenges facing a young adults with cancer. When I'm not working, you can find me exploring the outdoors with my family, traveling, and cooking. Dr. Grilley is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Bone Tumor, and Fibrosarcoma. Dr. Grilley is board certified in American Board Of Internal Med, Medical Oncology.
Frequently Asked Questions about Dr. Sanghee Hong
How do I make an appointment with Dr. Sanghee Hong?
You can book an appointment with Dr. Sanghee Hong by calling their office at 919-668-1002. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sanghee Hong a top-rated expert for Chronic Graft Versus Host Disease (cGvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sanghee Hong is classified as an Advanced expert for Chronic Graft Versus Host Disease (cGvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sanghee Hong specialize in?
While Dr. Sanghee Hong is a Hematology Oncology, they have specific expertise in Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Sanghee Hong participate in research or clinical trials?
Yes. Dr. Sanghee Hong has published 40 articles and abstracts on conditions like Chronic Graft Versus Host Disease (cGvHD). You can view a list of Dr. Sanghee Hong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sanghee Hong accept my insurance?
Dr. Sanghee Hong accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-668-1002 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Hong isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Hong isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Hong isExperienced. Learn about Acute Promyelocytic Leukemia.
- Blau SyndromeDr. Hong isExperienced. Learn about Blau Syndrome.



